Relationship of herpes simplex virus type-2 antibodies and squamous dysplasia to cervical carcinomain situ

scientific article published on December 1, 1978

Relationship of herpes simplex virus type-2 antibodies and squamous dysplasia to cervical carcinomain situ is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/1097-0142(197812)42:6<2716::AID-CNCR2820420629>3.0.CO;2-1
P953full work available at URLhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197812)42:6%3C2716::AID-CNCR2820420629%3E3.0.CO;2-1
https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197812)42:6%3C2716::AID-CNCR2820420629%3E3.0.CO;2-1
P698PubMed publication ID215294

P2093author name stringW. E. Rawls
D. B. Thomas
P2860cites workActa CytologicaQ15755265
Cancer ResearchQ326097
Infection with Mycoplasma pneumoniae: clinical and serological data on 286 patientsQ30789765
Chlamydial infection in women with cervical dysplasiaQ37912349
Quantitation of antibodies to Herpes simplex virus types 1 and 2 by complement-dependent antibody lysis of infected cellsQ39393674
Relative concentrations in human sera of antibodies to cross-reacting and specific antigens of Herpes simplex virus types 1 and 2Q39393682
The causative role of herpesvirus type 2 in cervical cancerQ39946854
Herpesvirus Antibodies and Antigens in Patients With Cervical Anaplasia and in Controls 2Q39958117
DYSPLASIA OF THE UTERINE CERVIX. INCIDENCE OF REGRESSION, RECURRENCE, AND CANCER.Q44474301
A study of herpes simplex type 2 antibody status in groups of patients with cervical neoplasia in CzechoslovakiaQ44581127
Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. IV. Dysplasia and carcinoma in situQ46534476
An epidemiologic study of carcinoma in situ and squamous dysplasia of the uterine cervixQ53708533
Antibodies to Herpesvirus hominis types 1 and 2 in humans. II. Women with cervical cancer.Q54059451
Contraceptive choice and prevalence of cervical dysplasia and carcinoma in situQ67441857
The association of genital herpesvirus with cervical atypia and carcinoma in situQ68609803
Antibodies to genital herpesvirus in patients with carcinoma of the cervixQ68611440
Neutralizing antibodies to herpesvirus types 1 and 2 in carcinoma of the cervix, carcinoma in situ and cervical dysplasiaQ68695463
Factors related to progression of cervical atypiasQ71748091
Dysplasia of the cervix: a prospective study of 206 casesQ72023318
Epidemiologic evidence for the spectrum of change from dysplasia through carcinoma in situ to invasive cancerQ72126214
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectoncologyQ162555
viral antibodiesQ66021534
P304page(s)2716-2725
P577publication date1978-12-01
P1433published inCancerQ326041
P1476titleRelationship of herpes simplex virus type-2 antibodies and squamous dysplasia to cervical carcinomain situ
P478volume42

Reverse relations

cites work (P2860)
Q45803424Cervical carcinoma: Detection of herpes simplex virus RNA in cells undergoing neoplastic change
Q43627401Expression and Cellular Compartmentalization of a Herpes Simplex Virus Type 2 Protein (ICP 10) in Productively Infected and Cervical Tumor Cells
Q72843587Expression of herpesvirus-induced antigens in human cervical cancer
Q39511005Herpes simplex type 2 virus and cervical neoplasia
Q40081313Herpes simplex virus type 2 and cervical cancer
Q36300454Herpesvirus-specific RNA and protein in carcinoma of the uterine cervix
Q39437447Papanicolaou test status among inner-city adolescent girls.
Q33848096Progression and regression of cervical lesions. Review of smears from women followed without initial biopsy or treatment
Q39700953The Pap smear revisited
Q45802798The chemotherapeutic exploitation of virus-specified enzymes
Q40127125“The herpesvirus hypothesis”—Are Koch's postulates satisfied?